• EMVision awarded $3m CRC-P grant to lead collaboration on accelerated stroke diagnosis and management in regional Australia
• Grant will fund clinical study to demonstrate benefits of EMVision's emu brain scanner in regional emergency departments
• First grant payment of $453,566 received

EMVision Medical Devices Limited (ASX:EMV) has executed the Cooperative Research Centres Projects (CRC-P) Grant Agreement with the Commonwealth of Australia, and has received the first grant payment of $453,566. Under this $3m grant, EMVision will lead a collaboration with the Australian Stroke Alliance, Titan Pre-hospital Innovation and South Australian Rural Support Service to demonstrate accelerated diagnosis and management of stroke patients in regional emergency departments, leading to improved outcomes for underserved rural Australians. The study will quantify the benefits of EMVision's emu brain scanner in stroke care workflows, including time savings in patient management decision making. This will be the first study to demonstrate the clinical utility of the emu brain scanner, which will form part of EMVision's evidence generation strategy to drive real-world adoption. Planning of the clinical benefit study is underway, with the study to commence in mid-2026. The CRC-P grant is a matched funding program, and progress reports will be provided quarterly, with the project anticipated to complete before September 2027.

EMVision is focused on demonstrating the clinical benefits of its emu brain scanner in this CRC-P funded study, which will form a key part of the company's evidence generation strategy to drive real-world adoption of its innovative neurodiagnostic devices.